Format

Send to

Choose Destination
Curr Opin Pharmacol. 2011 Oct;11(5):477-85. doi: 10.1016/j.coph.2011.07.007. Epub 2011 Aug 11.

Co-resistance: an opportunity for the bacteria and resistance genes.

Author information

1
Servicio de Microbiología and CIBER en Epidemiología y Salud Pública, Hospital Universitario Ramón y Cajal and Instituto Ramón y Cajal de Investigación Sanitaria, Carretera Colmenar Km 9.1. 28034 Madrid, Spain. rcanton.hrc@salud.madrid.org

Abstract

Co-resistance involves transfer of several genes into the same bacteria and/or the acquisition of mutations in different genetic loci affecting different antimicrobials whereas pleiotropic resistance implies the same genetic event affecting several antimicrobials. There is an increasing prevalence of isolates with co-resistance which are over-represented within the so-called high-risk clones. Compensatory events avoid fitness cost of co-resistance, even in the absence of antimicrobials. Nevertheless, they might be selected by different antimicrobials and a single agent might select co-resistant isolates. This process, named as co-selection, is not avoided with cycling or mixing strategies of antimicrobial use. Co-resistance and co-selection processes increase the opportunity for persistence of the bacteria and resistance genes and should be considered when designing strategies for decreasing antimicrobial resistance.

PMID:
21840259
DOI:
10.1016/j.coph.2011.07.007
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center